Winmark
WINA Nasdaq Other Specialty Retail Financials FY2016βFY2025
Winmark's revenue rose 5.9% to $86 million in fiscal 2025. Its operating margin was 63.4%, down from 65.1% a year earlier. Free cash flow was $45 million, up 6.5%. It paid out $52 million in dividends and buybacks, 115% of free cash flow. The diluted share count rose 0.5%.
What Winmark does
No business description yet.
- Legal name
- WINMARK CORPORATION
- Fiscal year ends
- December 27, 2025
- Latest annual report
- β
- Accession Β· CIK
- 0000908315-26-000007
0000908315
Revenue and margins
Winmark had $86.1M of revenue in fiscal 2025, up 5.9% on the year before.
Net income and earnings per share
From fiscal 2016 to 2025, diluted EPS grew 9.2% a year. Loss periods are shown in red.
Returns on capital
After-tax operating income as a share of the money invested in the business: debt plus equity, minus cash.
Cash flow
Free cash flow was $44.7M in fiscal 2025, 52.0% of revenue. Cash from operations minus capital spending.
Dividends, buybacks and share count
Winmark returned $51.5M to shareholders in fiscal 2025, 115% of free cash flow. The diluted share count rose 0.5%.
Value Winmark yourself
Change the assumptions and see what they imply per share. These are models, not forecasts or price targets β the answer depends entirely on what you put in.
Discounted cash flow
Value per share
β
Adds net cash of β$19.7M and divides by 3.7M diluted shares. Ten years of cash flows plus a terminal value, discounted to today.
Earnings multiple
Value per share
β
Reference multiples: today 25.0x Β· peers 20.1x Β· sector 17.7x.
Balance sheet
Cash, debt and the ratios that show how comfortably Winmark can carry it.
| Fiscal year end | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|
| Cash and short-term investments | $11.4M | $13.6M | $13.4M | $12.2M | $10.3M |
| Debt incl. finance leases | $47.7M | $43.3M | $39.1M | β | $30.0M |
| Net debt / EBITDA | 0.7x | 0.6x | 0.5x | β | 0.4x |
| Interest coverage | 35.3x | 18.4x | 17.2x | 18.5x | 22.3x |
| Current ratio | 1.8x | 1.7x | 1.6x | 3.0x | 2.5x |
| Quick ratio | 1.7x | 1.6x | 1.6x | 2.9x | 2.4x |
| Total assets | $26.9M | $30.5M | $29.0M | $26.8M | $24.9M |
| Total liabilities | $66.0M | $92.1M | $88.1M | $77.9M | $78.6M |
| Shareholders' equity | β$39.1M | β$61.6M | β$59.2M | β$51.0M | β$53.7M |
| Net debt (β = net cash) | $36.3M | $29.7M | $25.7M | β | $19.7M |
Insider trades
Open-market purchases and sales by officers, directors and 10% owners, from Form 4 filings. 'Plan' marks trades under a pre-arranged Rule 10b5-1 plan.
Bought, 12 months
$0.0M
0 insiders
Sold, 12 months
$3.6M
2 insiders
Of sales under plans
0%
$0.0M
| Date | Insider | Trade | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|
| Mar 4, 2026 | Jenele C GrassleDirector | Sold | 3,900 | $475.80 | $1.9M | Form 4 |
| Mar 3, 2026 | Percy C Tomlinson JrDirector | Sold | 1,660 | $460.52 | $0.8M | Form 4 |
| Nov 21, 2025 | Jenele C GrassleDirector | Sold | 2,400 | $420.87 | $1.0M | Form 4 |
| Oct 24, 2025 | Renae M. GaudetteChief Operating Officer | Sold | 1,200 | $417.11 | $0.5M | Form 4 |
Piotroski F-score
Nine pass/fail tests of profitability, funding and efficiency. 8β9 is strong, 0β2 weak.
| Test | FY23 | FY24 | FY25 |
|---|---|---|---|
| Net income is positive | β | β | β |
| Cash from operations is positive | β | β | β |
| Return on assets rose | β | β | β |
| Cash from operations exceeds net income | β | β | β |
| Debt fell relative to assets | β | β | β |
| Current ratio rose | β | β | β |
| Share count didn't rise | β | β | β |
| Gross margin rose | β | β | β |
| Revenue rose relative to assets | β | β | β |
| F-score | 4 / 9 | β / 9 | β / 9 |
| Accruals ratio | β12.8% | β7.9% | β12.5% |
| Altman Z'' | 5.55 | 7.08 | 6.65 |
Similar companies
Each company's latest fiscal year. Fiscal years end in different months, so periods don't line up exactly.
| Company | Market cap | Growth | Op. margin | FCF margin | ROIC | P/E | F-score | |
|---|---|---|---|---|---|---|---|---|
| Winmark WINA | $1.0B | 5.9% | 63.4% | 52.0% | β | 25.0x | β | |
| Bath & Body Works BBWI | $4.2B | β0.2% | 15.4% | 11.9% | 47.5% | 5.5x | 5 | Compare β |
| Ulta Beauty ULTA | $26.9B | 9.7% | 12.4% | 8.6% | 55.8% | 22.8x | 6 | Compare β |
| Chewy CHWY | $9.0B | 6.2% | 2.0% | 4.5% | β | 33.2x | 7 | Compare β |
| Tractor Supply TSCO | $17.5B | 4.3% | 9.5% | 4.8% | 28.5% | 17.4x | 6 | Compare β |
10 years of figures
US$ millions unless stated. Hover a ratio's name for its definition.
| Fiscal year | FY16 | FY17 | FY18 | FY19 | FY20 | FY21 | FY22 | FY23 | FY24 | FY25 |
|---|---|---|---|---|---|---|---|---|---|---|
| Income statement | ||||||||||
| Revenue | $66.5M | $69.8M | $72.5M | $73.3M | $66.1M | $78.2M | $81.4M | $83.2M | $81.3M | $86.1M |
| Gross profit | $64.4M | $67.3M | $69.8M | $70.8M | $64.0M | $75.3M | $77.7M | $78.8M | $77.9M | $83.0M |
| Operating income | $38.2M | $38.8M | $41.8M | $43.1M | $40.2M | $51.3M | $53.6M | $53.3M | $52.9M | $54.6M |
| Interest expense | $2.3M | $2.4M | $2.4M | $1.7M | $1.7M | $1.5M | $2.9M | $3.1M | $2.9M | $2.4M |
| Pretax income | $35.9M | $36.5M | $39.3M | $41.5M | $38.5M | $49.9M | $50.8M | $51.4M | $51.2M | $53.1M |
| Income tax | $13.7M | $11.9M | $9.2M | $9.3M | $8.7M | $9.9M | $11.4M | $11.2M | $11.3M | $11.5M |
| Net income | $22.1M | $24.6M | $30.1M | $32.1M | $29.8M | $39.9M | $39.4M | $40.2M | $40.0M | $41.7M |
| Diluted EPS | $5.11 | $5.66 | $7.26 | $7.84 | $7.72 | $10.48 | $10.97 | $11.04 | $10.89 | $11.30 |
| Diluted shares | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B | 0.00B |
| Cash flow | ||||||||||
| Cash from operations | $26.3M | $25.2M | $34.9M | $50.6M | $43.2M | $48.3M | $43.8M | $44.0M | $42.2M | $44.9M |
| Capital expenditure | $0.1M | $0.1M | $0.7M | $0.2M | $0.0M | $0.1M | $0.1M | $0.4M | $0.2M | $0.2M |
| Free cash flow | $26.2M | $25.1M | $34.2M | $50.5M | $43.2M | $48.3M | $43.7M | $43.6M | $42.0M | $44.7M |
| Depreciation and amortization | $0.4M | $0.4M | $0.3M | $0.4M | $0.5M | $0.4M | $0.6M | $0.8M | $0.8M | $0.7M |
| Stock-based compensation | $1.8M | $2.0M | $2.0M | $1.7M | $1.3M | $1.4M | $1.7M | $2.0M | $2.0M | $2.3M |
| Acquisitions | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Share buybacks | $1.6M | $49.9M | $1.8M | $24.0M | $49.0M | $44.2M | $49.1M | $0.0M | $0.0M | $2.4M |
| Dividends paid | $1.5M | $1.8M | $2.2M | $3.4M | $14.2M | $33.2M | $19.3M | $43.7M | $38.9M | $49.1M |
| Dividends and buybacks | $3.1M | $51.7M | $4.0M | $27.5M | $63.2M | $77.4M | $68.4M | $43.7M | $38.9M | $51.5M |
| Balance sheet | ||||||||||
| Cash and short-term investments | $1.3M | $1.1M | $2.5M | $25.1M | $6.7M | $11.4M | $13.6M | $13.4M | $12.2M | $10.3M |
| Total debt | $21.9M | $32.1M | $28.8M | $25.7M | $21.9M | $47.7M | $43.3M | $39.1M | β | $30.0M |
| Finance lease liabilities | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M | $0.0M |
| Current assets | $22.8M | $21.5M | $24.3M | $41.2M | $18.3M | $17.4M | $18.1M | $16.7M | $15.4M | $14.1M |
| Current liabilities | $7.4M | $9.4M | $12.5M | $11.9M | $11.4M | $10.0M | $10.6M | $10.5M | $5.1M | $5.7M |
| Inventory | $0.1M | $0.1M | $0.1M | $0.1M | $0.1M | $0.3M | $0.8M | $0.4M | $0.4M | $0.4M |
| Property and equipment, net | $0.8M | $0.5M | $0.9M | $2.8M | $2.3M | $2.0M | $1.7M | $1.7M | $1.4M | $1.2M |
| Total assets | $48.6M | $48.8M | $46.7M | $61.8M | $31.3M | $26.9M | $30.5M | $29.0M | $26.8M | $24.9M |
| Total liabilities | $61.5M | $84.6M | $51.5M | $49.4M | $42.7M | $66.0M | $92.1M | $88.1M | $77.9M | $78.6M |
| Shareholders' equity | β$12.9M | β$35.7M | β$4.8M | $12.4M | β$11.4M | β$39.1M | β$61.6M | β$59.2M | β$51.0M | β$53.7M |
| Margins | ||||||||||
| Gross margin | 96.8% | 96.5% | 96.2% | 96.6% | 96.8% | 96.2% | 95.4% | 94.6% | 95.8% | 96.4% |
| Operating margin | 57.4% | 55.6% | 57.6% | 58.8% | 60.9% | 65.6% | 65.9% | 64.0% | 65.1% | 63.4% |
| EBITDA margin | 58.1% | 56.1% | 58.0% | 59.4% | 61.6% | 66.2% | 66.6% | 64.9% | 66.1% | 64.3% |
| Net margin | 33.3% | 35.2% | 41.6% | 43.9% | 45.1% | 51.0% | 48.4% | 48.3% | 49.2% | 48.4% |
| FCF margin | 39.4% | 36.0% | 47.2% | 68.9% | 65.4% | 61.7% | 53.6% | 52.4% | 51.6% | 52.0% |
| Returns | ||||||||||
| Return on capital | β | β | 380.7% | 193.6% | 368.4% | β | β | β | β | β |
| Return on capital employed | 94.2% | 96.3% | 113.5% | 102.6% | 115.1% | 278.4% | 291.5% | 277.8% | 262.9% | 266.5% |
| Return on equity | β | β | β | 841.6% | β | β | β | β | β | β |
| Return on assets | 46.2% | 50.5% | 63.1% | 59.3% | 64.0% | 137.1% | 137.5% | 135.2% | 143.2% | 161.1% |
| Growth | ||||||||||
| Revenue growth | β4.2% | 4.9% | 4.0% | 1.1% | β9.9% | 18.4% | 4.1% | 2.3% | β2.4% | 5.9% |
| Net income growth | 1.6% | 11.0% | 22.6% | 6.7% | β7.2% | 33.9% | β1.2% | 1.9% | β0.6% | 4.3% |
| EPS growth | 9.0% | 10.8% | 28.3% | 8.0% | β1.5% | 35.8% | 4.7% | 0.6% | β1.4% | 3.8% |
| FCF growth | 18.1% | β4.1% | 36.2% | 47.4% | β14.5% | 11.8% | β9.6% | β0.1% | β3.8% | 6.5% |
| Share count change | β6.9% | 0.2% | β4.4% | β1.2% | β5.8% | β1.4% | β5.7% | 1.3% | 0.7% | 0.5% |
| Financial health | ||||||||||
| Net debt / EBITDA | 0.5x | 0.8x | 0.6x | 0.0x | 0.4x | 0.7x | 0.6x | 0.5x | β | 0.4x |
| Debt / equity | β | β | β | 2.1x | β | β | β | β | β | β |
| Interest coverage | 16.3x | 16.4x | 17.1x | 24.9x | 23.1x | 35.3x | 18.4x | 17.2x | 18.5x | 22.3x |
| Current ratio | 3.1x | 2.3x | 1.9x | 3.5x | 1.6x | 1.8x | 1.7x | 1.6x | 3.0x | 2.5x |
| Quick ratio | 3.1x | 2.3x | 1.9x | 3.5x | 1.6x | 1.7x | 1.6x | 1.6x | 2.9x | 2.4x |
| Capital allocation | ||||||||||
| Capex / revenue | 0.1% | 0.1% | 1.0% | 0.2% | 0.1% | 0.1% | 0.2% | 0.5% | 0.2% | 0.2% |
| Stock comp / revenue | 2.7% | 2.8% | 2.7% | 2.3% | 2.0% | 1.8% | 2.0% | 2.4% | 2.5% | 2.7% |
| Payouts / FCF | 11.8% | 205.6% | 11.7% | 54.4% | 146.4% | 160.3% | 156.7% | 100.1% | 92.6% | 115.3% |
| Quality scores | ||||||||||
| Piotroski F-score | 8.0 | 5.0 | 7.0 | 9.0 | 6.0 | 7.0 | 7.0 | 4.0 | β | β |
| Altman Z'' | 6.4 | 4.0 | 6.9 | 8.1 | 7.6 | 9.3 | 6.0 | 5.6 | 7.1 | 6.7 |
| Accruals ratio | β8.6% | β1.3% | β10.1% | β34.1% | β28.8% | β28.9% | β15.2% | β12.8% | β7.9% | β12.5% |
Source: SEC EDGAR XBRL filings (CIK 0000908315). Data updated October 20, 2026. Quarterly fourth quarters are the full year minus the first nine months. For information only β not investment advice. Check the original filings before relying on any figure.